Eletriptan Hydrobromide and Moxetumomab Pasudotox-tdfk
Determining the interaction of Eletriptan Hydrobromide and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eletriptan
Brand name: Relpax
Synonyms: Eletriptan
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eletriptan Hydrobromide-Moxetumomab pasudotox-tdfk Intravenous
- Eletriptan Hydrobromide-Moxifloxacin
- Eletriptan Hydrobromide-Moxifloxacin (Systemic)
- Eletriptan Hydrobromide-Moxifloxacin Hydrochloride
- Eletriptan Hydrobromide-Moxifloxacin Injection
- Eletriptan Hydrobromide-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Elexacaftor, Tezacaftor and Ivacaftor
- Moxetumomab Pasudotox-tdfk-Elfolate
- Moxetumomab Pasudotox-tdfk-Elidel
- Moxetumomab Pasudotox-tdfk-Elidel Topical
- Moxetumomab Pasudotox-tdfk-Eligard
- Moxetumomab Pasudotox-tdfk-Eliglustat